○Quy Pham Nguyen1,5, Chau Duc Nguyen Huu2, Nam Ha Xuan2, Thao Ngan Nguyen Thi2, Hong Tram Nguyen Thi2, Thanh Thu Nguyen Thi2, Hong Duyen Nguyen2, Khoi Quan Nguyen2, Minh Trang Nguyen Ho3, Hiep Pham Nhu4, Thanh Xuan Nguyen4, Kiem Hao Tran4, Van Ha Chau4, Diem Chi Nguyen Thi4, Huu Son Nguyen4, Tomohiro Kondo5, Shigemi Matsumoto6 (1.Department of Medical Oncology, Kyoto Miniren Central Hospital, 2.Hue University of Medicine and Pharmacy, Vietnam, 3.College of Economics, Hue University, Vietnam, 4.Pediatric Center, Hue Central Hospital, Vietnam, 5.Department of Medical Oncology, Graduate School of Medicine, Kyoto University, 6.Department of Real World Data Research and Development, Graduate School of Medicine, Kyoto University)
Session information
Mini-Oral Session
[MO35] Mini-Oral Session 35 Palliative Care / Symptom Management 1
【E】
Sat. Feb 19, 2022 8:20 AM - 9:10 AM Room 6 (Room D, 1F, Kyoto International Conference Center)
Chair:Hideki Katayama(Department of Palliative and Supportive Care, Okayama University Hospital),Terufumi Kato(Department of Thoracic Oncology, Kanagawa Cancer Center Department of Thoracic Oncology)
○Yoshiki Horie1, Tempei Miyaji2, Takashi Kawaguchi3, Takako Kaneyasu4, Fumio Nagashima5, Ayako Doi1, Yu Uneno6, Takashi Ogura1, Takuhiro Yamaguchi7, Takako Nakajima8 (1.Department of Clinical Oncology St. Marianna University School of Medicine, 2.Department of Clinical Trial Data Management, Graduate School of Medicine, The University of Tokyo, 3.Tokyo University of Pharmacy and Life Sciences Department of Practical Pharmacy, 4.College of Life Sciences, Department of Biomedical Sciences, Ritsumeikan University, 5.Department of Medical Oncology, Kyorin University Faculty of Medicine, 6.Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, 7.Division of Biostatistics, Tohoku University Graduate School of Medicine, 8.Department of Early Clinical Development, Kyoto University Graduate School of Medicine)
○Danielle Francesca A. Leonardo, Jose Roberto G. Amparo (Section of Medical Oncology, National Kidney and Transplant Institute)
○Tomofumi Miura1, Yoshihisa Matsumoto1, Shuji Hiramoto2, Ayumi Okizaki3, Takeshi Hirohashi4, Masanori Mori5 (1.Department of Palliative Medicine, National Cancer Center Hospital East, 2.Peace Home Care Clinic, 3.Division of Supportive Care, Survivorship and Translational Research, National Cancer Center Institute for Cancer Control, 4.Cancer Support and Palliative Care Center, Eiju General Hospital, 5.Palliative Care Team, Seirei Mikatahara General Hospital)
○Daisuke Arai1, Takashi Sato2, Ichiro Nakachi1, Daisuke Fujisawa3, Mari Takeuchi4, Yasunori Sato5, Ichiro Kawada6, Hiroyuki Yasuda6, Shinnosuke Ikemura6, Hideki Terai6, Takashi Inoue7, Morio Nakamura8, Yoshitaka Oyamada9, Takeshi Terashima10, Koichi Sayama11, Fumitake Saito12, Fumio Sakamaki13, Katsuhiko Naoki2, Koichi Fukunaga6, Kenzo Soejima14 (1.Department of Ineternal Medicine, Saiseikai Utsunomiya Hospital, 2.Department of Respiratory Medicine, Kitasato University School of Medicine,, 3.Division of Patient Safety, Keio University School of Medicine, 4.Palliative Care Center, Keio University School of Medicine, 5.Department of Preventive Medicine and Public Health, Keio University School of Medicine, 6.Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 7.Department of Internal Medicine, Sano-Kosei General Hospital, 8.Division of Pulmonary Medicine, National Hospital Organization Kanagawa Hospital, 9.Department of Respiratory Medicine, National Hospital Organization Tokyo Medical Center, 10.Department of Internal Medicine, Tokyo Saiseikai Central Hospital, 11.Division of Pulmonary Medicine, Kawasaki Municipal Hospital, 12.Department of Pulmonary Medicine, Eiju General Hospital, 13.Division of Pulmonary Medicine, Department of Medicine, Tokai University Hachioji Hospital, 14.Clinical and Translational Research Center, Keio University Hospital)
○Nobu Akiyama1, Takuho Okamura2, Minoru Yoshida3, Shun-Ichi Kimura4, Shingo Yano5, Isao Yoshida6, Hitoshi Kusaba7, Kosuke Takahashi8, Hiroyuki Fujita9, Keitaro Fukushima10, Hiromichi Iwasaki11, Kazuo Tamura12, Toshiaki Saeki13, Yasushi Takamatsu14, Sadamoto Zenda15 (1.Center for Blood Tranfusion and Cell-therapy, Teikyo University, 2.Department of Breast Surgery, School of Medicine, Tokai University, 3.Fourth Department of Internal Medicine, Teikyo University Hospital Mizonokuchi, 4.Division of Hematology, Jichi Medical University Saitama Medical Center, 5.Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, 6.National Hospital Organization Shikoku Cancer Center, Department of Hematologic Oncology, 7.Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, 8.Department of Respiratory Medicine, Anjo Kosei Hospital, 9.Department of Hematology, Saiseikai Yokohama Nanbu Hospital, 10.Department of Pediatrics, Dokkyo Medical University, 11.Department of Infection Control and Prevention, Faculty of Medical Sciences, University of Fukui, 12.Professor Emeritus, Fukuoka University, 13.Department of Breast Oncology, Saitama Medical University International Medical Center, 14.Department of Hematology, Oncology, Endocrinology and Infectious disease, Fukuoka University, Fukuoka, 15.National Cancer Center Hospital East, Department of Radiation Oncology)